News & Events
Exciting Liver Health Helix Event on Wednesday, 4 June 2025
The upcoming Liver Health Helix Event on Wednesday, 04 June 2025, from 11:00 - 12:30 CEST (10:00 - 11:30 BST) about the challenges of drug development for clinical trials is an exciting open innovation event designed to accelerate the development of new treatments for liver diseases, particularly severe alcoholic hepatitis (sAH), advanced cirrhosis, and acute-on-chronic liver failure (ACLF). Taking place in support of the A-TANGO project and related research initiatives, this event brings together leading hepatologists, cirrhosis researchers, industry professionals, and investors to explore the latest breakthroughs, share expertise, and spark impactful collaborations. Now is the time to secure your spot in this vibrant and forward-thinking community. Register here!
Meet the Experts: Speaker Lineup at the Helix Event
Our Liver Health Helix Event on 04 June 2025 features an exceptional lineup of speakers from the fields of hepatology, clinical research, drug development, and bioinformatics. Troels Jordansen, CEO of Yaqrit, Cornelius Engelmann, clinical trial supervisor at the Charité, Burcu Kiper, Impact Acceleration Manager at Crowdhelix, and guest speaker Salvador Augustin from Boehringer Ingelheim will keep you on your toes. They will share valuable insights into the latest therapeutic strategies, innovative approaches, and ways to overcome the challenges of clinical trials. Attendees will benefit from firsthand knowledge, real-world case studies, and opportunities to engage directly with some of the brightest minds in liver disease research and drug development.
The Agenda: Challenges of Drug Development for Clincal Trials
Feeling optimistic about incorporating both drug development and drug manufacturing into your 5-year-long EU-funded research project? Well, according to Troels Jordanson, CEO of Yaqrit, "if it can go wrong, it ...". The upcoming Helix Event on 04 June 2025 is packed with fun and interactive sessions designed to foster knowledge exchange and drive real progress in liver disease treatment. Topics will range from drug development bottlenecks and clinical trial design to cutting-edge applications in data science and bioinformatics. Dedicated networking opportunities and panel discussions will allow participants to explore shared challenges and uncover new paths toward collaboration. The program is designed to inspire innovation and equip attendees with actionable insights that can lead to meaningful change. Don't forget to register for this exciting online session!